Medicines derived from UK blood plasma distributed to NHS hospitals for ‘first time in a generation’ More than 250,000 litres of plasma from UK donors have been sent to human protein product manufacturer Octapharma to produce NHS medicines for the first time since a 1998 ban.…
Downing Street announces full inquiry into contaminated blood scandal A full statutory public inquiry will be held to examine how thousands of people were given contaminated blood transfusions during the 1970s and 1980s.…
FDA approves coagulation factor-albumin fusion protein to treat haemophilia B Idelvion, a coagulation factor-albumin fusion protein product for use in children and adults with haemophilia B, has been approved by the US Food and Drug Administration.…
FDA approves Factor X therapy for rare bleeding condition The US Food and Drug Administration has approved a purified clotting factor for patients with hereditary Factor X deficiency.…
